nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—TP53—peripheral nervous system neoplasm	0.025	0.857	CrCbGaD
Nitazoxanide—Acetylsalicylic acid—ABCB1—peripheral nervous system neoplasm	0.00415	0.143	CrCbGaD
Nitazoxanide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00239	0.00246	CcSEcCtD
Nitazoxanide—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00237	0.00244	CcSEcCtD
Nitazoxanide—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00237	0.00244	CcSEcCtD
Nitazoxanide—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00233	0.0024	CcSEcCtD
Nitazoxanide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00233	0.0024	CcSEcCtD
Nitazoxanide—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00239	CcSEcCtD
Nitazoxanide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00231	0.00238	CcSEcCtD
Nitazoxanide—Chills—Etoposide—peripheral nervous system neoplasm	0.00229	0.00236	CcSEcCtD
Nitazoxanide—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00228	0.00235	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00228	0.00235	CcSEcCtD
Nitazoxanide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00228	0.00234	CcSEcCtD
Nitazoxanide—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00227	0.00234	CcSEcCtD
Nitazoxanide—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00233	CcSEcCtD
Nitazoxanide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00226	0.00233	CcSEcCtD
Nitazoxanide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00226	0.00233	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00225	0.00232	CcSEcCtD
Nitazoxanide—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00224	0.00231	CcSEcCtD
Nitazoxanide—Oedema—Vincristine—peripheral nervous system neoplasm	0.00224	0.0023	CcSEcCtD
Nitazoxanide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00223	0.0023	CcSEcCtD
Nitazoxanide—Infection—Vincristine—peripheral nervous system neoplasm	0.00222	0.00229	CcSEcCtD
Nitazoxanide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00222	0.00228	CcSEcCtD
Nitazoxanide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00228	CcSEcCtD
Nitazoxanide—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.0022	0.00227	CcSEcCtD
Nitazoxanide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0022	0.00226	CcSEcCtD
Nitazoxanide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0022	0.00226	CcSEcCtD
Nitazoxanide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00219	0.00225	CcSEcCtD
Nitazoxanide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00219	0.00225	CcSEcCtD
Nitazoxanide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00218	0.00224	CcSEcCtD
Nitazoxanide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00217	0.00223	CcSEcCtD
Nitazoxanide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00217	0.00223	CcSEcCtD
Nitazoxanide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00217	0.00223	CcSEcCtD
Nitazoxanide—Back pain—Etoposide—peripheral nervous system neoplasm	0.00215	0.00221	CcSEcCtD
Nitazoxanide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00214	0.00221	CcSEcCtD
Nitazoxanide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00214	0.0022	CcSEcCtD
Nitazoxanide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00214	0.0022	CcSEcCtD
Nitazoxanide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00213	0.0022	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00218	CcSEcCtD
Nitazoxanide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00211	0.00218	CcSEcCtD
Nitazoxanide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.00216	CcSEcCtD
Nitazoxanide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.00216	CcSEcCtD
Nitazoxanide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0021	0.00216	CcSEcCtD
Nitazoxanide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00207	0.00213	CcSEcCtD
Nitazoxanide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00206	0.00213	CcSEcCtD
Nitazoxanide—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00206	0.00213	CcSEcCtD
Nitazoxanide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00206	0.00213	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00206	0.00212	CcSEcCtD
Nitazoxanide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00205	0.00211	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00205	0.00211	CcSEcCtD
Nitazoxanide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00204	0.00211	CcSEcCtD
Nitazoxanide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00204	0.0021	CcSEcCtD
Nitazoxanide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00204	0.0021	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00204	0.0021	CcSEcCtD
Nitazoxanide—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00204	0.0021	CcSEcCtD
Nitazoxanide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00209	CcSEcCtD
Nitazoxanide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00209	CcSEcCtD
Nitazoxanide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00202	0.00208	CcSEcCtD
Nitazoxanide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00202	0.00208	CcSEcCtD
Nitazoxanide—Malaise—Etoposide—peripheral nervous system neoplasm	0.002	0.00206	CcSEcCtD
Nitazoxanide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00205	CcSEcCtD
Nitazoxanide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00205	CcSEcCtD
Nitazoxanide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00198	0.00204	CcSEcCtD
Nitazoxanide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00198	0.00204	CcSEcCtD
Nitazoxanide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00204	CcSEcCtD
Nitazoxanide—Infection—Cisplatin—peripheral nervous system neoplasm	0.00197	0.00202	CcSEcCtD
Nitazoxanide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00196	0.00202	CcSEcCtD
Nitazoxanide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00195	0.00201	CcSEcCtD
Nitazoxanide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00195	0.00201	CcSEcCtD
Nitazoxanide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00195	0.00201	CcSEcCtD
Nitazoxanide—Rash—Topotecan—peripheral nervous system neoplasm	0.00195	0.00201	CcSEcCtD
Nitazoxanide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00195	0.002	CcSEcCtD
Nitazoxanide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00195	0.002	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00194	0.00199	CcSEcCtD
Nitazoxanide—Headache—Topotecan—peripheral nervous system neoplasm	0.00193	0.00199	CcSEcCtD
Nitazoxanide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00199	CcSEcCtD
Nitazoxanide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00199	CcSEcCtD
Nitazoxanide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00199	CcSEcCtD
Nitazoxanide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00199	CcSEcCtD
Nitazoxanide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00199	CcSEcCtD
Nitazoxanide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00192	0.00198	CcSEcCtD
Nitazoxanide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00192	0.00198	CcSEcCtD
Nitazoxanide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00192	0.00198	CcSEcCtD
Nitazoxanide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00192	0.00197	CcSEcCtD
Nitazoxanide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00197	CcSEcCtD
Nitazoxanide—Constipation—Vincristine—peripheral nervous system neoplasm	0.00191	0.00197	CcSEcCtD
Nitazoxanide—Pain—Vincristine—peripheral nervous system neoplasm	0.00191	0.00197	CcSEcCtD
Nitazoxanide—Rash—Melphalan—peripheral nervous system neoplasm	0.00191	0.00196	CcSEcCtD
Nitazoxanide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00191	0.00196	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00196	CcSEcCtD
Nitazoxanide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00194	CcSEcCtD
Nitazoxanide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00187	0.00192	CcSEcCtD
Nitazoxanide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00185	0.0019	CcSEcCtD
Nitazoxanide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00189	CcSEcCtD
Nitazoxanide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00189	CcSEcCtD
Nitazoxanide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00183	0.00189	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00183	0.00188	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00182	0.00188	CcSEcCtD
Nitazoxanide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00187	CcSEcCtD
Nitazoxanide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00187	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.0018	0.00186	CcSEcCtD
Nitazoxanide—Infection—Etoposide—peripheral nervous system neoplasm	0.0018	0.00185	CcSEcCtD
Nitazoxanide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.0018	0.00185	CcSEcCtD
Nitazoxanide—Nausea—Melphalan—peripheral nervous system neoplasm	0.0018	0.00185	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00179	0.00185	CcSEcCtD
Nitazoxanide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00184	CcSEcCtD
Nitazoxanide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00177	0.00182	CcSEcCtD
Nitazoxanide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00177	0.00182	CcSEcCtD
Nitazoxanide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00177	0.00182	CcSEcCtD
Nitazoxanide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00173	0.00178	CcSEcCtD
Nitazoxanide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00172	0.00177	CcSEcCtD
Nitazoxanide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00176	CcSEcCtD
Nitazoxanide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.00176	CcSEcCtD
Nitazoxanide—Pain—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00174	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00174	CcSEcCtD
Nitazoxanide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00167	0.00172	CcSEcCtD
Nitazoxanide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00167	0.00172	CcSEcCtD
Nitazoxanide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.0017	CcSEcCtD
Nitazoxanide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00165	0.0017	CcSEcCtD
Nitazoxanide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00169	CcSEcCtD
Nitazoxanide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00168	CcSEcCtD
Nitazoxanide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00161	0.00166	CcSEcCtD
Nitazoxanide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00161	0.00165	CcSEcCtD
Nitazoxanide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00159	0.00164	CcSEcCtD
Nitazoxanide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00164	CcSEcCtD
Nitazoxanide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00158	0.00163	CcSEcCtD
Nitazoxanide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00158	0.00162	CcSEcCtD
Nitazoxanide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00161	CcSEcCtD
Nitazoxanide—Pain—Etoposide—peripheral nervous system neoplasm	0.00155	0.0016	CcSEcCtD
Nitazoxanide—Constipation—Etoposide—peripheral nervous system neoplasm	0.00155	0.0016	CcSEcCtD
Nitazoxanide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00159	CcSEcCtD
Nitazoxanide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00158	CcSEcCtD
Nitazoxanide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00153	0.00158	CcSEcCtD
Nitazoxanide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.0015	0.00155	CcSEcCtD
Nitazoxanide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00149	0.00154	CcSEcCtD
Nitazoxanide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00149	0.00153	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00148	0.00153	CcSEcCtD
Nitazoxanide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00148	0.00152	CcSEcCtD
Nitazoxanide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00152	CcSEcCtD
Nitazoxanide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00151	CcSEcCtD
Nitazoxanide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00151	CcSEcCtD
Nitazoxanide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00146	0.0015	CcSEcCtD
Nitazoxanide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.0015	CcSEcCtD
Nitazoxanide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00147	CcSEcCtD
Nitazoxanide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00142	0.00147	CcSEcCtD
Nitazoxanide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Rash—Vincristine—peripheral nervous system neoplasm	0.00141	0.00145	CcSEcCtD
Nitazoxanide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00141	0.00145	CcSEcCtD
Nitazoxanide—Headache—Vincristine—peripheral nervous system neoplasm	0.0014	0.00144	CcSEcCtD
Nitazoxanide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00143	CcSEcCtD
Nitazoxanide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00142	CcSEcCtD
Nitazoxanide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00139	CcSEcCtD
Nitazoxanide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00134	0.00138	CcSEcCtD
Nitazoxanide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00133	0.00137	CcSEcCtD
Nitazoxanide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00137	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Nitazoxanide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Nitazoxanide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.0013	0.00134	CcSEcCtD
Nitazoxanide—Chills—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00132	CcSEcCtD
Nitazoxanide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00128	0.00132	CcSEcCtD
Nitazoxanide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Nitazoxanide—Rash—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00128	CcSEcCtD
Nitazoxanide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00128	CcSEcCtD
Nitazoxanide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00124	0.00128	CcSEcCtD
Nitazoxanide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00126	CcSEcCtD
Nitazoxanide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00124	CcSEcCtD
Nitazoxanide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.0012	0.00123	CcSEcCtD
Nitazoxanide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00123	CcSEcCtD
Nitazoxanide—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00122	CcSEcCtD
Nitazoxanide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00121	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00119	CcSEcCtD
Nitazoxanide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00115	0.00119	CcSEcCtD
Nitazoxanide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00119	CcSEcCtD
Nitazoxanide—Rash—Etoposide—peripheral nervous system neoplasm	0.00114	0.00118	CcSEcCtD
Nitazoxanide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00114	0.00118	CcSEcCtD
Nitazoxanide—Headache—Etoposide—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Nitazoxanide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Nitazoxanide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00116	CcSEcCtD
Nitazoxanide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00115	CcSEcCtD
Nitazoxanide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00115	CcSEcCtD
Nitazoxanide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00114	CcSEcCtD
Nitazoxanide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00113	CcSEcCtD
Nitazoxanide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00108	0.00111	CcSEcCtD
Nitazoxanide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00111	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.0011	CcSEcCtD
Nitazoxanide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.0011	CcSEcCtD
Nitazoxanide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00109	CcSEcCtD
Nitazoxanide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00108	CcSEcCtD
Nitazoxanide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00107	CcSEcCtD
Nitazoxanide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00107	CcSEcCtD
Nitazoxanide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00106	CcSEcCtD
Nitazoxanide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00105	CcSEcCtD
Nitazoxanide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00104	CcSEcCtD
Nitazoxanide—Infection—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00104	CcSEcCtD
Nitazoxanide—Shock—Epirubicin—peripheral nervous system neoplasm	0.001	0.00103	CcSEcCtD
Nitazoxanide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000995	0.00102	CcSEcCtD
Nitazoxanide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000992	0.00102	CcSEcCtD
Nitazoxanide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000981	0.00101	CcSEcCtD
Nitazoxanide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000969	0.000998	CcSEcCtD
Nitazoxanide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000969	0.000998	CcSEcCtD
Nitazoxanide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000959	0.000988	CcSEcCtD
Nitazoxanide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00094	0.000968	CcSEcCtD
Nitazoxanide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000934	0.000962	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000926	0.000953	CcSEcCtD
Nitazoxanide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000925	0.000953	CcSEcCtD
Nitazoxanide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000919	0.000947	CcSEcCtD
Nitazoxanide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000918	0.000945	CcSEcCtD
Nitazoxanide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000903	0.00093	CcSEcCtD
Nitazoxanide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.000923	CcSEcCtD
Nitazoxanide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000894	0.000921	CcSEcCtD
Nitazoxanide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000883	0.00091	CcSEcCtD
Nitazoxanide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000869	0.000895	CcSEcCtD
Nitazoxanide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000869	0.000895	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000857	0.000882	CcSEcCtD
Nitazoxanide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00085	0.000876	CcSEcCtD
Nitazoxanide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000837	0.000862	CcSEcCtD
Nitazoxanide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000836	0.000861	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000831	0.000856	CcSEcCtD
Nitazoxanide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000828	0.000852	CcSEcCtD
Nitazoxanide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000817	0.000842	CcSEcCtD
Nitazoxanide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.000828	CcSEcCtD
Nitazoxanide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.000828	CcSEcCtD
Nitazoxanide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000803	0.000827	CcSEcCtD
Nitazoxanide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000803	0.000827	CcSEcCtD
Nitazoxanide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000775	0.000798	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000769	0.000792	CcSEcCtD
Nitazoxanide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000749	0.000771	CcSEcCtD
Nitazoxanide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000765	CcSEcCtD
Nitazoxanide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000765	CcSEcCtD
Nitazoxanide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000729	0.000751	CcSEcCtD
Nitazoxanide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000719	0.00074	CcSEcCtD
Nitazoxanide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000695	0.000716	CcSEcCtD
Nitazoxanide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000693	0.000713	CcSEcCtD
Nitazoxanide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.000695	CcSEcCtD
Nitazoxanide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000672	0.000692	CcSEcCtD
Nitazoxanide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000665	0.000685	CcSEcCtD
Nitazoxanide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000646	0.000665	CcSEcCtD
Nitazoxanide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000663	CcSEcCtD
Nitazoxanide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000641	0.00066	CcSEcCtD
Nitazoxanide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00064	0.000659	CcSEcCtD
Nitazoxanide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000637	0.000656	CcSEcCtD
Nitazoxanide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.00064	CcSEcCtD
Nitazoxanide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000622	CcSEcCtD
Nitazoxanide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.000616	CcSEcCtD
Nitazoxanide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.000611	CcSEcCtD
Nitazoxanide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.00061	CcSEcCtD
Nitazoxanide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000607	CcSEcCtD
Nitazoxanide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000575	CcSEcCtD
